SCHEMBL4745901

SCHEMBL4745901

CC([O])CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13717323 0.80
SCHEMBL9402276 0.79 TSHR (0.53)
SCHEMBL3714954 0.78
SCHEMBL6448801 0.78
SCHEMBL364463 0.78
SCHEMBL5077944 0.76 SLC22A6 (0.50)
SCHEMBL304303 0.76 SLC22A6 (0.50)
3-Methylbutanoic Acid SCHEMBL467274 0.76 TDP1 (0.56)
3-Methylbutanoic Acid SCHEMBL43436 0.76
3-Methylbutanoic Acid SCHEMBL1331498 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008112674-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2008-09-18 WO claimed
US-20230348438-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2023-11-02 US disclosed
US-20210284627-A1 INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2021-09-16 US disclosed
EP-3766877-A1 INDOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 2021-01-20 EP disclosed
US-20200317644-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2020-10-08 US disclosed
US-20200255408-A1 INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2020-08-13 US disclosed
EP-3524599-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 2019-08-14 EP disclosed
US-20180362506-A1 INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2018-12-20 US disclosed
US-20180346449-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2018-12-06 US disclosed
US-20170267662-A1 INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2017-09-21 US disclosed
US-5591752-A LEUKOTRIENE ANTAGONIST, ANTIALLERGEN, ANTIINFLAMMATORY AGENT, DIBENZ(B,E)OXEPINE UBE INDUSTRIES, LTD. (JP) 1997-01-07 US disclosed
WO-1996021647-A1 SUBSTITUTED 2-PHENYLPYRIDINES AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1996-07-18 WO disclosed
EP-0685478-A1 QUINOLINE DERIVATIVE UBE INDUSTRIES, LTD. (JP) 1995-12-06 EP disclosed
EP-0045081-B1 TRISUBSTITUTED IMIDAZOLE DERIVATIVES, PROCESSES FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE CIBA-GEIGY AG (CH) 1986-01-08 EP disclosed
US-4447431-A VIRICIDES, ANTIINFLAMMATORY AND SUNCREEN AGENT CIBA-GEIGY CORPORATION (US) 1984-05-08 US disclosed
WO-1983002613-A1 TRISUBSTITUTED OXAZO COMPOUNDS SALLMANN, ALFRED 1983-08-04 WO disclosed
WO-1983002611-A1 TRISUBSTITUTED DIAZO COMPOUNDS SALLMANN, ALFRED 1983-08-04 WO disclosed
EP-0084756-A1 Trisubstituted oxaza compounds CIBA-GEIGY AG (CH) 1983-08-03 EP disclosed
EP-0084757-A1 Trisubstituted diaza derivatives CIBA-GEIGY AG (CH) 1983-08-03 EP disclosed
EP-0045081-A2 Trisubstituted imidazole derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use CIBA-GEIGY AG (CH) 1982-02-03 EP disclosed